A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients (Q77896423)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

J M Morgan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D M Capuzzi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J R Guyton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

12A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

29U-34U; discussion 39U-41U

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9915660%20AND%20SRC:MED&resulttype=core&format=json

The effects of nicotinic acid treatment on high density lipoprotein particle size subclass levels in hyperlipidaemic subjects

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Effect of low-dose niacin on high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Tolerance to nicotinic acid flushing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Niacin and hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Fulminant hepatic failure after ingestion of sustained-release nicotinic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Acute hepatic failure associated with the use of low-dose sustained-release niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Precipitation methods for quantification of lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Differences in metabolism of time-release and unmodified nicotinic acid: Explanation of the differences in hypolipidemic action?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Pharmacokinetics of nicotinic acid-salicylic acid interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2

Nicotinic acid-induced fulminant hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900732-2